SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-034165
Filing Date
2020-12-16
Accepted
2020-12-16 18:42:39
Documents
1
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14469
  Complete submission text file 0000899243-20-034165.txt   16721
Mailing Address C/O COLUMN GROUP LP 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
GOEDDEL DAVID V (Reporting) CIK: 0001182464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 201393713

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
COLUMN GROUP L P (Reporting) CIK: 0001347769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 201393712

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address
Svennilson Peter (Reporting) CIK: 0001606074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 201393714